Search

Author/Creator Durrant, Simon

2. A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia. Issue 5 (May 2015)

Authors:
He, Simon Z.; Busfield, Samantha; Ritchie, David S.; Hertzberg, Mark S.; Durrant, Simon; Lewis, Ian D.; Marlton, Paula; McLachlan, Andrew J.; Kerridge, Ian; Bradstock, Kenneth F.; Kennedy, Glen; Boyd, Andrew W.; Yeadon, Trina M.; Lopez, Angel F.; Ramshaw, Hayley S.; Iland, Harry; Bamford, Simone;...
Journal:
Leukemia & lymphoma
Issue:
Volume 56:Issue 5(2015:May)
Page Start:
1406
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A prospective phase II randomized study of deferasirox to prevent iatrogenic iron overload in patients undertaking induction/consolidation chemotherapy for acute myeloid leukaemia. (17th April 2013)

Authors:
Kennedy, Glen A.; Morris, Kirk L.; Subramonpillai, Elango; Curley, Cameron; Butler, Jason; Durrant, Simon
Journal:
British journal of haematology
Issue:
Volume 161:Number 6(2013:Jun.)
Page Start:
794
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trial. Issue 3 (March 2015)

Authors:
Lickliter, Jason D.; Taylor, Kerry; Szer, Jeff; Grigg, Andrew; Arthur, Christopher; Hughes, Timothy P.; Durrant, Simon; Filshie, Robin; Irving, Ian; Seldon, Michael; Ellacott, Jennifer; Boyd, Andrew W.; D'Rozario, James; Rooney, Kim; Lynch, Kevin; Bradstock, Ken
Journal:
Leukemia & lymphoma
Issue:
Volume 56:Issue 3(2015:Mar.)
Page Start:
630
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia. Issue 9 (29th July 2019)

Authors:
Dombret, Hervé; Topp, Max S.; Schuh, Andre C.; Wei, Andrew H.; Durrant, Simon; Bacon, Christopher Larry; Tran, Qui; Zimmerman, Zachary; Kantarjian, Hagop
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 9(2019)
Page Start:
2214
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up. Issue 7 (28th April 2014)

Authors:
Gambacorti‐Passerini, Carlo; Brümmendorf, Tim H.; Kim, Dong‐Wook; Turkina, Anna G.; Masszi, Tamas; Assouline, Sarit; Durrant, Simon; Kantarjian, Hagop M.; Khoury, H. Jean; Zaritskey, Andrey; Shen, Zhi‐Xiang; Jin, Jie; Vellenga, Edo; Pasquini, Ricardo; Mathews, Vikram; Cervantes, Francisco; Besson...
Journal:
American journal of hematology
Issue:
Volume 89:Issue 7(2014:Jul.)
Page Start:
732
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Changes in quality of life and disease‐related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy. (3rd January 2016)

Authors:
Mesa, Ruben; Verstovsek, Srdan; Kiladjian, Jean‐Jacques; Griesshammer, Martin; Masszi, Tamas; Durrant, Simon; Passamonti, Francesco; Harrison, Claire N.; Pane, Fabrizio; Zachee, Pierre; Zhen, Huiling; Jones, Mark M.; Parasuraman, Shreekant; Li, Jingjin; Côté, Isabelle; Habr, Dany; Vannucchi, Ales...
Journal:
European journal of haematology
Issue:
Volume 97:Number 2(2016:Aug.)
Page Start:
192
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide. (17th May 2017)

Authors:
Harrison, Claire N.; Griesshammer, Martin; Miller, Carole; Masszi, Tamas; Passamonti, Francesco; Zachee, Pierre; Durrant, Simon; Pane, Fabrizio; Guglielmelli, Paola; Verstovsek, Srdan; Jones, Mark M.; Hunter, Deborah S.; Sun, William; Li, Jingjin; Khan, Mahmudul; Habr, Dany; Kiladjian, Jean‐Jacques
Journal:
British journal of haematology
Issue:
Volume 182:Number 2(2018)
Page Start:
279
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Corrigendum to "KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study" [Leuk. Res. 50 (Nov) (2016) 123–131. PubMed PMID: 27736729]. (August 2017)

Authors:
Swords, Ronan T.; Greenberg, Peter L.; Wei, Andrew H.; Durrant, Simon; Advani, Anjali S.; Hertzberg, Mark S.; Lewis, Ian D.; Rivera, Gabriel; Gratzinger, Dita; Fan, Alice C.; Felsher, Dean W.; Cortes, Jorge E.; Watts, Justin M.; Yarranton, Geoff T.; Walling, Jackie M.; Lancet, Jeffrey E.
Journal:
Leukemia research
Issue:
Volume 59(2017:Aug.)
Page Start:
65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Effects of cognitive behavioural therapy on insomnia in adults with tinnitus: Systematic review and meta-analysis of randomised controlled trials. (April 2021)

Authors:
Curtis, Ffion; Laparidou, Despina; Bridle, Chris; Law, Graham R.; Durrant, Simon; Rodriguez, Alina; Pierzycki, Robert H.; Siriwardena, Aloysius N.
Journal:
Sleep medicine reviews
Issue:
Volume 56(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗